The C-terminal cytoplasmic tail of the AT2 receptor plays a critical role in modulating its ligand binding affinity and intracellular signaling properties.
Answers are grounded in this paper and cite their sources.
AT2 C-terminal tail modulates receptor function in cells; leaves open therapeutic targeting in cardiovascular disease.
A stop codon at position 322 was introduced to generate a truncated, C-terminal-deleted AT2 receptor. Expression studies in Xenopus oocytes showed that C-terminal-deleted AT2 had reduced affinity to [(125)I]angiotensin II (K(d)=1.7 nM) and enhanced binding of the AT2-specific peptidic ligand [(125)I]CGP42112A (K(d)=0.097 nM). AT2 activation by angiotensin II resulted in reduction of cGMP levels in oocytes and this reduction was further enhanced by C-terminal deletion, implying that the C-terminus may have a negative effect on the AT2-mediated cGMP reduction. Moreover, interaction of the AT2 with the ATP-binding domain of the human ErbB3 receptor in yeast two-hybrid assay was abolished by C-terminal deletion. In summary, the C-terminal cytoplasmic tail of AT2 modulates its ligand binding and signaling properties.
No takes yet. Share an insight, caveat, or question.
Pulakat et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: